Ranitidine Dosing in Children
For children aged 1 month to 16 years, the recommended dose of ranitidine is 2 to 4 mg/kg twice daily (maximum 300 mg/day) for treatment of duodenal and gastric ulcers, or 5 to 10 mg/kg/day in divided doses for GERD and erosive esophagitis. For infants under 1 month of age, data are insufficient to make firm dosing recommendations, though limited evidence suggests lower doses may be appropriate due to reduced renal clearance 1.
Age-Specific Dosing Recommendations
Infants Under 1 Month
- Insufficient data exist for routine dosing recommendations in neonates less than 1 month old 1
- Plasma clearance in neonates is considerably lower (3 mL/min/kg) compared to older children or adults, likely due to reduced renal function 1
- Research evidence suggests:
Critical caveat: The pharmacokinetics in neonates differ substantially from older children, with prolonged half-life and reduced clearance requiring careful dose adjustment and monitoring 1, 2.
Children 1 Month to 16 Years
For duodenal and gastric ulcers 1:
- Treatment: 2 to 4 mg/kg twice daily (maximum 300 mg/day)
- Maintenance: 2 to 4 mg/kg once daily (maximum 150 mg/day)
For GERD and erosive esophagitis 1:
- 5 to 10 mg/kg/day in 2 divided doses is the recommended range
- This higher dosing reflects the need for more sustained acid suppression in reflux disease
Special Considerations for Anaphylaxis
In the acute management of anaphylaxis, ranitidine dosing differs 4:
- 12.5 to 50 mg (1 mg/kg) in children
- Dilute in 5% dextrose to total volume of 20 mL
- Inject intravenously over 5 minutes
- Important: This is second-line therapy to epinephrine and should never be used alone
Dosing Nuances Based on Research Evidence
Critically Ill Children
Research demonstrates that standard dosing may be inadequate in intensive care settings 5:
- Minimum 3 mg/kg/day IV is required for adequate gastric pH control (pH ≥4)
- 71% of patients receiving <3 mg/kg/day had poor pH control versus only 19% receiving ≥3 mg/kg/day
- Doses should be titrated to maintain gastric pH ≥4
Duration of Acid Suppression
Evidence suggests higher doses provide more sustained effect 6:
- Doses ≥3 mg/kg/dose maintain gastric pH >4 for >6 hours
- Doses <3 mg/kg/dose show declining efficacy after 4 hours
- For extended acid suppression, doses at the higher end of the range (4-5 mg/kg twice daily) may be necessary
Renal Impairment Adjustment
For creatinine clearance <50 mL/min 1:
- Reduce to 150 mg every 24 hours in adults
- May increase frequency to every 12 hours if clinically required
- Pediatric dose adjustment should be proportional
- Time dosing to coincide with end of hemodialysis when applicable
Practical Administration Considerations
Formulation Options
- Tablets: Standard dosing as above
- Syrup: 15 mg/mL peppermint-flavored formulation
- Effervescent tablets: 25 mg tablets dissolved in 5 mL water, citrus-flavored
- Preferred by 71% of children over syrup in taste studies 7
- May improve compliance in pediatric patients
Bioavailability
- Oral bioavailability is approximately 48-50% in children, comparable to adults 1
- Food and antacids do not significantly impair absorption
- Peak levels occur 2-3 hours after oral dosing
Common Pitfalls to Avoid
Underdosing in critically ill children: Standard reference ranges (2-4 mg/kg/day) may be insufficient in ICU settings; start at minimum 3 mg/kg/day 5
Inadequate dosing for GERD: Reflux disease requires higher doses (5-10 mg/kg/day) and more frequent administration (3 times daily) compared to ulcer treatment 1, 8
Failure to adjust for renal function: Ranitidine is primarily renally excreted; dose reduction is essential in renal impairment 1
Inappropriate use in neonates <1 month: Reduced clearance necessitates lower doses and longer intervals; extrapolating from older pediatric dosing can lead to toxicity 1, 2
Expecting immediate effect: Peak acid suppression occurs 2-3 hours post-dose; plan timing accordingly for procedures or symptom control 1